Dr. Gorgun Akpek, MD, MHS

Dr. Akpek practices at Slo Oncology & Hematology Health Center in Santa Maria, California.

Dr. Akpek's NPI, 1124068515, was assigned on June 7, 2006. Dr. Akpek graduated from Hacettepe University FOM in 1985. Dr. Akpek's California license number on file is C152104.

Dr. Akpek's primary practice is Slo Oncology & Hematology Health Center, at 117 W Bunny Ave, Santa Maria, CA 93458 in Santa Barbara County. The practice phone is (805) 543-5577.

Dr. Akpek's primary practice is Slo Oncology & Hematology Health Center in Santa Maria, California. Dr. Akpek is also affiliated with Dignity Health - Marian Regional Medical Center. The medical group on file is Pacific Central Coast Health Centers Medical Group. Dmand AI also links Dr. Akpek to 3 more hospitals, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akpek practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Akpek's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Akpek is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Akpek's licenses on file in 6 states: California, Illinois, Delaware, Arizona, Maryland and Massachusetts.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Akpek treats.

CMS data shows 2,245 Medicare services from Dr. Akpek across 11 procedure codes in 2024, for 511 Medicare patients. Medicare paid $200,130 for them. Every service was in an office.

CMS counts 511 Medicare patients who saw Dr. Akpek in 2024. The largest group is 65 to 74, with 212 patients. 72% of them have high blood pressure, and 71% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akpek's median patient age at 72, with 53% women.

In 2024, Dr. Akpek wrote 728 Medicare Part D claims for 153 patients. 76% of them were for generic drugs. CMS names the drug for 488 of them, across 18 drugs with 11 or more claims each, at $838,389 in total drug cost. In 2023, CMS named 463 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Akpek for performance year 2024, reported through an alternative payment model (APM). Dr. Akpek accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Akpek as offering telehealth.

Dmand AI links 50 papers to Dr. Akpek, published from 2003 to 2021. 2015 was the busiest year, with 5. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Transplantation, Homologous. Dr. Akpek has published most often in Bone Marrow Transplant. Dr. Akpek's most frequent co-authors are Aaron Paul Rapoport, MD, Uday R. Popat, MD and Jack W. Hsu, MD.

Dmand AI links Dr. Akpek to 2 clinical trials. Conditions studied include Bronchiolitis Obliterans Syndrome, Burkitt Lymphoma and Epstein-Barr Virus Infections. Medical College of Wisconsin sponsors the most, 2.

CMS Open Payments shows 1,382 general payments to Dr. Akpek from 91 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. Sanofi and Genzyme US Companies paid the most, $9,150.

Dmand AI lists 1 award for Dr. Akpek.

Dr. Akpek graduated from Hacettepe University FOM in 1985. Dr. Akpek is a member of ACP.

Dr. Akpek is in network with 14 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.